World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
65
Citations
11586
World Ranking
9394
National Ranking
4143

D. Martin Watterson publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where D. Martin Watterson sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 201 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

D. Martin Watterson D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where D. Martin Watterson sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 65 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

D. Martin Watterson is affiliated with Northwestern University in the United States. Their research spans multiple areas within Medicine and Neuroscience, with a focus on fields such as Immunology, Physiology, Cellular and Molecular Neuroscience, Pharmacology, and Psychiatry and Mental Health. The main topics covered in their work include Alzheimer's disease research and treatments, Neuroscience and Neuropharmacology Research, Neuroinflammation and Neurodegeneration Mechanisms, Cell Adhesion Molecules Research, Immune cells in cancer, Cholinesterase and Neurodegenerative Diseases, and Dementia and Cognitive Impairment Research.

Among the recent papers authored or co-authored by Watterson are:

  • Involvement of p38 MAPK in Synaptic Function and Dysfunction, 2020, International Journal of Molecular Sciences
  • PI3Kγ stimulates a high molecular weight form of myosin light chain kinase to promote myeloid cell adhesion and tumor inflammation, 2022, Nature Communications
  • First-in-Human Studies of MW01-6-189WH, a Brain-Penetrant, Antineuroinflammatory Small-Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers, 2020, Clinical Pharmacology in Drug Development
  • The 5HT2b Receptor in Alzheimer's Disease: Increased Levels in Patient Brains and Antagonist Attenuation of Amyloid and Tau Induced Dysfunction, 2024, Journal of Alzheimer s Disease
  • Therapeutic treatment with the anti-inflammatory drug candidate MW151 may partially reduce memory impairment and normalizes hippocampal metabolic markers in a mouse model of comorbid amyloid and vascular pathology, 2022, PLoS ONE

Frequent co-authors collaborating with Watterson include:

  • Saktimayee M. Roy
  • Ottavio Arancio
  • Linda J. Van Eldik
  • Erica Acquarone
  • Jeffrey C. Pelletier

Watterson's work has appeared in journals such as:

  • Alzheimer s & Dementia
  • International Journal of Molecular Sciences
  • Nature Communications
  • Journal of Alzheimer s Disease
  • Clinical Pharmacology in Drug Development

Best Publications

  • Epithelial myosin light chain kinase–dependent barrier dysfunction mediates T cell activation–induced diarrhea in vivo

    Daniel R. Clayburgh;Terrence A. Barrett;Yueming Tang;Jon B. Meddings

  • Targeting protein kinases in central nervous system disorders

    Laura K. Chico;Linda J. Van Eldik;D. Martin Watterson

  • A novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model

    Lenka Munoz;Lenka Munoz;Hantamalala Ralay Ranaivo;Saktimayee M Roy;Wenhui Hu;Wenhui Hu

  • Microglial p38α MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Aβ).

    Adam D Bachstetter;Bin Xing;Lucia de Almeida;Edgardo R Dimayuga

  • Calcium-Binding Proteins and the Molecular Basis of Calcium Action

    Linda J. Van Eldik;Joseph G. Zendegui;Daniel R. Marshak;D. Martin Watterson

  • Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injury

    Eric Lloyd;Kathleen Somera-Molina;Kathleen Somera-Molina;Linda J Van Eldik;D Martin Watterson

  • Glia as a therapeutic target: selective suppression of human amyloid-beta-induced upregulation of brain proinflammatory cytokine production attenuates neurodegeneration.

    Hantamalala Ralay Ranaivo;Jeffrey M. Craft;Wenhui Hu;Ling Guo

  • Glia Proinflammatory Cytokine Upregulation as a Therapeutic Target for Neurodegenerative Diseases: Function‐Based and Target‐Based Discovery Approaches

    Linda J. Van Eldik;Wendy L. Thompson;Hantamalala Ralay Ranaivo;Heather A. Behanna

  • Protein kinase involved in lung injury susceptibility: Evidence from enzyme isoform genetic knockout and in vivo inhibitor treatment

    Mark S. Wainwright;Janet Rossi;James Schavocky;Susan Crawford

  • Calmodulin and signal transduction

    Linda J. van Eldik;D. Martin Watterson

  • Mechanism of glial activation by S100B: involvement of the transcription factor NFκB

    Amy G.M Lam;Tanuja Koppal;Keith T Akama;Ling Guo

  • Glial activation links early-life seizures and long-term neurologic dysfunction : Evidence using a small molecule inhibitor of proinflammatory cytokine upregulation

    Kathleen C. Somera-Molina;Beverley Robin;Cherie Ann Somera;Christopher Anderson

  • A kinase-related protein stabilizes unphosphorylated smooth muscle myosin minifilaments in the presence of ATP.

    V P Shirinsky;A V Vorotnikov;K G Birukov;A K Nanaev

  • Spinach calmodulin: isolation, characterization, and comparison with vertebrate calmodulins.

    D. Martin Watterson;David B. Iverson;Linda J. Van Eldik

  • Neuroinflammation: a potential therapeutic target.

    Jeffrey M Craft;D Martin Watterson;Linda J Van Eldik

  • Human amyloid β-induced neuroinflammation is an early event in neurodegeneration

    Jeffrey M. Craft;D. Martin Watterson;Linda J. Van Eldik

  • Structural characterization of a higher plant calmodulin : spinacia oleracea.

    Thomas J. Lukas;David B. Iverson;Michael Schleicher;D. Martin Watterson

  • Affinity chromatography purification of a cyclic nucleotide phosphodiesterase using immobilized modulator protein, a troponin C-like protein from brain.

    D.Martin Watterson;Thomas C. Vanaman

  • Aminopyridazines inhibit β-amyloid-induced glial activation and neuronal damage in vivo

    Jeffrey M. Craft;D.Martin Watterson;Sally A. Frautschy;Linda J.Van Eldik

  • An aminopyridazine-based inhibitor of a pro-apoptotic protein kinase attenuates hypoxia-ischemia induced acute brain injury.

    Anastasia V. Velentza;Mark S. Wainwright;Magdalena Zasadzki;Salida Mirzoeva

Frequent Co-Authors

Linda J. Van Eldik
Linda J. Van Eldik University of Kentucky
Linda J. Van Eldik
Linda J. Van Eldik University of Kentucky
Jacques Haiech
Jacques Haiech University of Strasbourg
Adam D. Bachstetter
Adam D. Bachstetter University of Kentucky
Ottavio Arancio
Ottavio Arancio Columbia University
Daniel M. Roberts
Daniel M. Roberts University of Tennessee at Knoxville
Wayne F. Anderson
Wayne F. Anderson Northwestern University
Michael Schleicher
Michael Schleicher Ludwig-Maximilians-Universität München
Daniel R. Marshak
Daniel R. Marshak Cold Spring Harbor Laboratory
Konstantin G. Birukov
Konstantin G. Birukov University of Chicago

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing D. Martin Watterson

Trending Scientists

Recently Published Articles